Wesana Health Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WSNAF research report →
Price Chart
About the company
Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI). The company focuses on pioneering scientifically validated compounds and therapeutic strategies.
- CEO
- Daniel Carcillo
- IPO
- 2021
- Employees
- 7
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on WSNAF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $73.22K
- P/E
- -0.07
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.45
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -506.80%
- ROIC
- 4706.52%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,124,906
- Net Income
- $-1,754,771+79.6%
- EPS
- $-0.05+79.1%
- OCF Growth
- +88.7%
- FCF Growth
- +88.7%
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- -0.70
- RSI (14)
- 3
- Avg Volume
- 37
No earnings-call transcripts are available for WSNAF yet.
- Free Float
- 98.0%
- Shares Outstanding
- 20.92M
- Float Shares
- 20.49M
Our WSNAF coverage
Recent articles, reports, and earnings notes.
No research on WSNAF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WSNAF report →Wesana Health Announces Change to The Board of Directors
newsfilecorp.com · Jan 24
Wesana Health Announces Restructuring of Promissory Note Receivable
newsfilecorp.com · Nov 28
CSE Bulletin: Symbol Change - Inactive Designation - Wesana Health Holdings Inc. (WESA)
newsfilecorp.com · Jul 11
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
benzinga.com · Jan 11
Wesana Health CEO leveraging personal and professional experience to help patients achieve better mental health outcomes
proactiveinvestors.com · Dec 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.